The Harvard Clinical and Translational Science Center
The Harvard Clinical and Translational Science Center
批准号:
10398988
负责人:
Lee Marshall Nadler
金额:
$1286.73万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-05-01 至 2023-06-15
关键词:
AddressAgreementAttentionBiological SciencesCenter for Translational Science ActivitiesClinical ResearchClinical SciencesClinical TrialsClinical Trials NetworkCollaborationsCommunitiesCompetenceComplexConceptionsDataData SetDevelopmentDiagnosisDisciplineEaglesEcosystemElectronic Health RecordEnsureEvaluationEvolutionFacultyFosteringFutureGoalsGrantHealthHealth SciencesHealthcareHumanIncentivesIndividualInformaticsInfrastructureInstitutional Review BoardsKnowledgeLearningLongevityMedical StudentsMethodologyMethodsMissionNational Center for Advancing Translational SciencesOhioOregonPatientsPerformancePopulationProcessResearch MethodologyResearch PersonnelResourcesRiskScheduleSchoolsScienceSpecial PopulationSpeedSumSystemTalentsTechnologyTrainingTraining SupportTranslational ResearchTranslationsUniversitiesWorkforce Developmentcatalystclinical translationcohorteducation resourcesevidence baseexperimental studygraduate studentimprovedinformatics infrastructureinnovationmembermultidisciplinarynew technologynext generationopen innovationopen sourcepreventresearch studyskillssuccesssystems researchtooltranslational research program
中文摘要
联系PD/PI:纳德勒,李·马歇尔
英文摘要
Contact PD/PI: Nadler, Lee Marshall
OVERALL: ABSTRACT
By convening, connecting, and catalyzing the formation of multi-institutional, cross-disciplinary teams from
across Harvard's (HU) 10 schools and 16 independent academic health centers (AHCs), Harvard Catalyst
(HC) has fostered a “One Harvard” community and culture that has transformed the quality, efficiency, and
impact of clinical and translation (CT) research at HU. HC's commitment to make the whole of the HU CT
research enterprise greater than the sum of its parts has led to the development and continuous evolution of
12 innovative and integrated Cores focused on training the 21st century CT workforce, addressing the needs of
patients and their communities, and incentivizing and prioritizing collaboration, team science, and stakeholder
engagement. HC Cores have developed workflows, processes, methodologies, tools, and technologies to
support the training and needs of T0-T4 CT investigators, their teams, community stakeholders, and the HU
ecosystem, and have collected qualitative and quantitative data to demonstrate their value at HU hub. Once
demonstrated, HC shares its learning as open source with other CTSAs and the CTSA consortium. To date,
Profiles, i2b2 SHRINE (now Accrual to Clinical Trials ACT Network), Master Reliance Agreements and online
reliance systems (now SMART IRB), eagle-i, Scheduler, online educational resources (initiating the N-lighten
Network), and open innovation experiments have been disseminated to the CTSA consortium.
Going forward to fully align with NCATS' strategic goals, HC will implement five specific aims: Workforce
Development (Aim 1) will support the broadly defined educational needs of the present and future CT
workforce inclusive of all CT research domains, disciplines, medical and graduate students, post-graduate
trainees, investigators, multi-disciplinary team members, and communities of collaborators. Research Methods
and Processes (Aim 2) will provide “everything necessary” to execute CT research including methods,
processes, workflows, pilot grants, novel technologies, and integrated data sets necessary for investigators
and their teams to succeed locally and in collaboration with communities and the CTSA consortium. Integration
(Aim 3) will ensure that translational science is interconnected across all T domains and is inclusive of the
needs of special populations and individuals across their entire lifespan. Collaboration and Engagement (Aim
4) will promote team science by extending the CT research community beyond its traditional academic
borders. It engages and partners with our patients, communities, and our diverse ecosystem to participate in
prioritization decisions and gap analysis. Informatics (Aim 5) will respond to the needs of CT investigators,
teams, patients, and communities by providing enabling processes, methodologies, and tools. HC Learning CT
Research System will enable HC to study the science of CT science and develop evidence-based strategies to
improve the conduct of CT research thereby increasing its impact on human health. HC will continue to share
all resources developed and lessons learned with the CTSA consortium.
Project Summary/Abstract Page 362
Contact PD/PI: Nadler, Lee Marshall
Harvard Catalyst | The Harvard Clinical and Translational Science Center, connects, convenes, and catalyzes
the faculty, trainees, and teams from across Harvard's 10 Schools and 16 Academic Healthcare Center to partner
with its communities and biomedical ecosystem to address NCATS' five strategic goals to improve health.
期刊论文(205)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.xfre.2022.01.004
发表时间:
2022-03
期刊:
F&S reports
影响因子:
--
作者:
[Domar AD, Shah JS, Gompers A, Meyers AJ, Khodakhah DR, Hacker MR, Penzias AS, Sakkas D, Toth TL, Vaughan DA]
通讯作者:
Vaughan DA
DOI:
10.1017/cts.2023.517
发表时间:
2023
期刊:
JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE
影响因子:
2.6
作者:
[Green, Jonathan M., Goodman, Polly, Kirby, Aaron, Cobb, Nichelle, Bierer, Barbara E.]
通讯作者:
Bierer, Barbara E.
DOI:
10.1097/pas.0000000000001929
发表时间:
2022-10-01
期刊:
AMERICAN JOURNAL OF SURGICAL PATHOLOGY
影响因子:
5.6
作者:
[Costigan, Danielle C., Nucci, Marisa R., Dickson, Brendan C., Chang, Martin C., Song, Sharon, Sholl, Lynette M., Hornick, Jason L., Fletcher, Christopher D. M., Kolin, David L.]
通讯作者:
Kolin, David L.
DOI:
10.1111/josh.13203
发表时间:
2022-12
期刊:
JOURNAL OF SCHOOL HEALTH
影响因子:
2.2
作者:
[Plummer, Rachel S., Alter, Zanny, Lee, Rebekka M., Gordon, Allegra R., Cory, Hannah, Brion-Meisels, Gretchen, Reiner, Jennifer, Topping, Kimm, Kenney, Erica L.]
通讯作者:
Kenney, Erica L.
Cost-effectiveness of prophylactic antibiotic use to prevent catheter-associated urinary tract infections.
预防性使用抗生素预防导管相关尿路感染的成本效益。
DOI:
10.1007/s00192-019-04034-4
发表时间:
2020
期刊:
International urogynecology journal
影响因子:
1.8
作者:
[Wang,Rui, Hacker,MicheleR, Lefevre,Roger]
通讯作者:
Lefevre,Roger
共 122 条
Harvard Clinical and Translational Science Center
-
批准号:10622007
-
项目类别:
-
资助金额:$1090.42万
-
财政年份:2023
-
负责人:Lee Marshall Nadler
-
依托单位:
SMART IRB, A NATIONAL SINGLE IRB RELIANCE PLATFORM TO SUPPORT MULTI-SITE HUMAN RESEARCH STUDIES
-
批准号:10370538
-
项目类别:
-
资助金额:$183.68万
-
财政年份:2018
-
负责人:Lee Marshall Nadler
-
依托单位:
The Harvard Clinical and Translational Science Center
-
批准号:10457151
-
项目类别:
-
资助金额:$19.18万
-
财政年份:2018
-
负责人:Lee Marshall Nadler
-
依托单位:
The Harvard Clinical and Translational Science Center
-
批准号:9916834
-
项目类别:
-
资助金额:$1898.77万
-
财政年份:2018
-
负责人:Lee Marshall Nadler
-
依托单位:
The Harvard Clinical and Translational Science Center
-
批准号:10375725
-
项目类别:
-
资助金额:$24.68万
-
财政年份:2018
-
负责人:Lee Marshall Nadler
-
依托单位:
Harvard Clinical and Translational Science Center
-
批准号:8721093
-
项目类别:
-
资助金额:$1240.59万
-
财政年份:2013
-
负责人:Lee Marshall Nadler
-
依托单位:
Harvard Clinical and Translational Science Center
-
批准号:8721083
-
项目类别:
-
资助金额:$113.12万
-
财政年份:2013
-
负责人:Lee Marshall Nadler
-
依托单位:
Harvard Clinical and Translational Science Center
-
批准号:8721090
-
项目类别:
-
资助金额:$60.52万
-
财政年份:2013
-
负责人:Lee Marshall Nadler
-
依托单位:
Harvard Clinical and Translational Science Center
-
批准号:8921897
-
项目类别:
-
资助金额:$54.49万
-
财政年份:2013
-
负责人:Lee Marshall Nadler
-
依托单位:
Harvard Clinical and Translational Science Center
-
批准号:9315452
-
项目类别:
-
资助金额:$12.93万
-
财政年份:2013
-
负责人:Lee Marshall Nadler
-
依托单位:
Harvard Clinical and Translational Science Center
-
批准号:8743344
-
项目类别:
-
资助金额:$61.15万
-
财政年份:2013
-
负责人:Lee Marshall Nadler
-
依托单位:
Harvard Clinical and Translational Science Center
-
批准号:8743343
-
项目类别:
-
资助金额:$173.83万
-
财政年份:2013
-
负责人:Lee Marshall Nadler
-
依托单位:
Harvard Clinical and Translational Science Center
-
批准号:9070039
-
项目类别:
-
资助金额:$62.41万
-
财政年份:2013
-
负责人:Lee Marshall Nadler
-
依托单位:
Harvard Clinical and Translational Science Center
-
批准号:8922083
-
项目类别:
-
资助金额:$179.96万
-
财政年份:2013
-
负责人:Lee Marshall Nadler
-
依托单位:
Harvard Clinical and Translational Science Center
-
批准号:9070038
-
项目类别:
-
资助金额:$175.2万
-
财政年份:2013
-
负责人:Lee Marshall Nadler
-
依托单位:
Harvard Clinical and Translational Science Center
-
批准号:9070040
-
项目类别:
-
资助金额:$2188.68万
-
财政年份:2013
-
负责人:Lee Marshall Nadler
-
依托单位:
Harvard Clinical and Translational Science Center
-
批准号:8922084
-
项目类别:
-
资助金额:$2191.19万
-
财政年份:2013
-
负责人:Lee Marshall Nadler
-
依托单位:
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
-
批准号:8365091
-
项目类别:
-
资助金额:$419.05万
-
财政年份:2011
-
负责人:Lee Marshall Nadler
-
依托单位:
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
-
批准号:8365090
-
项目类别:
-
资助金额:$733.32万
-
财政年份:2011
-
负责人:Lee Marshall Nadler
-
依托单位:
HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)
-
批准号:8365089
-
项目类别:
-
资助金额:$879.99万
-
财政年份:2011
-
负责人:Lee Marshall Nadler
-
依托单位:
海外基金